PanGen Biotech Inc Cash Flow Conversion Efficiency

Latest as of September 2025: -0.122x

PanGen Biotech Inc cash flow conversion efficiency. Based on the latest financial reports, PanGen Biotech Inc (222110) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.66 Billion ≈ $-2.48 Million USD) by net assets (₩30.03 Billion ≈ $20.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of PanGen Biotech Inc (2014–2024)

Cash flow conversion efficiency of PanGen Biotech Inc from 2014 to 2024. This chart illustrates how PanGen Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 222110 stock price and chart for real-time trading data and today's change.

PanGen Biotech Inc Cash Flow Conversion Ratio Explained

PanGen Biotech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PanGen Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PanGen Biotech Inc ranked by their cash flow conversion efficiency. Also see PanGen Biotech Inc (222110) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sambo Motors Co. Ltd KQ:053700	0.071x
Buima Group TWO:5543	-0.158x
SMCore.Inc KQ:007820	-0.082x
Stablecoin Development Corporation NYSE MKT:SDEV	0.100x
Helbor Empreendimentos S.A SA:HBOR3	-0.033x
Grande Portage Resources Ltd V:GPG	-0.019x
Saeron Auto KO:075180	0.042x
Delticom AG F:DEX	-0.008x

Annual Cash Flow Conversion Efficiency for PanGen Biotech Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of PanGen Biotech Inc from 2014 to 2024. Review PanGen Biotech Inc (222110) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.91 Billion ≈ $16.88 Million	₩2.99 Billion ≈ $2.02 Million	0.120x	+143.67%
2023-12-31	₩12.57 Billion ≈ $8.52 Million	₩-3.45 Billion ≈ $-2.34 Million	-0.275x	-35.00%
2022-12-31	₩17.22 Billion ≈ $11.67 Million	₩-3.50 Billion ≈ $-2.37 Million	-0.203x	-29.11%
2021-12-31	₩21.10 Billion ≈ $14.30 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.158x	+52.17%
2020-12-31	₩14.21 Billion ≈ $9.63 Million	₩-4.68 Billion ≈ $-3.17 Million	-0.329x	-65.73%
2019-12-31	₩18.43 Billion ≈ $12.49 Million	₩-3.66 Billion ≈ $-2.48 Million	-0.199x	+4.56%
2018-12-31	₩26.94 Billion ≈ $18.26 Million	₩-5.61 Billion ≈ $-3.80 Million	-0.208x	-891.15%
2017-12-31	₩31.31 Billion ≈ $21.22 Million	₩-657.84 Million ≈ $-445.81K	-0.021x	+82.93%
2016-12-31	₩35.31 Billion ≈ $23.93 Million	₩-4.35 Billion ≈ $-2.94 Million	-0.123x	+49.74%
2015-12-31	₩6.56 Billion ≈ $4.45 Million	₩-1.61 Billion ≈ $-1.09 Million	-0.245x	-95.31%
2014-12-31	₩10.69 Billion ≈ $7.24 Million	₩-1.34 Billion ≈ $-908.12K	-0.125x	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$37.49 Million

₩55.33 Billion KRW

Market Cap Rank

#22756 Global

#1497 in Korea

Share Price

₩4100.00

Change (1 day)

-0.24%

52-Week Range

₩4100.00 - ₩7340.00

All Time High

₩24450.00